Additive Therapy for Advanced Stages of Glaucoma
Purpose of the study: to evaluate the efficacy and feasibility of using brimonidine 0.2 % in the additive therapy of patients with advanced stages of glaucoma. Materials and methods. There were 59 patients (77 eyes) with advanced stages of primary open-angle, glaucoma (POAG) aged 68 to 83 years in t...
Saved in:
Main Authors: | I. R. Gazizova, V. E. Korelina, E. P. Goncharuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2023-10-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/2183 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy, Tolerability and Adverse Effects of Triple Fixed Dose Combination Brimonidine–Brinzolamide–Timolol Ophthalmic Suspension in Primary Open Angle Glaucoma: A Retrospective Study
by: Hina Kounsar, et al.
Published: (2025-04-01) -
Efficacy and safety of 0.1 % brimonidine as a starting monotherapy and when added to combination therapy of glaucoma
by: E. D. Semenov, et al.
Published: (2024-12-01) -
Repeated micropulse cyclophotocoagulation in the treatment of refractory glaucoma. A clinical experience
by: I. E. Ioshin, et al.
Published: (2022-09-01) -
New Opportunities in Non-Preservative Glaucoma Therapy
by: A. A. Antonov, et al.
Published: (2021-07-01) -
Micropulse cyclophotocoagulation in the treatment of various types of glaucoma. Part 2: MPCPC at different stages of glaucoma, in combined ophthalmopathology and in congenital glaucoma
by: O. V. Ermakova, et al.
Published: (2025-03-01)